Teva to buy Allergan generic drug business for $40.5 billion
Collapse
X
-
Tags: None
-
It's just bigger pharma buying out others and getting bigger. I don't care if I had a quality hairloss drug, 40 billion is 40billion, nobodies waiting around for that haha. After reading up on Teva they are huge players so it could be a good sign!Comment
-
Just to note this is only their business in terms of selling cheaper generic drugs so I'm really not sure what this means. So Allergan still have the double chin drug and seti right? So this 40 billion could mean they at least have the finances to do more phases ect. Maybe this is a way to get around the issues facing Bim in terms of being unable to patent maybe? This division as I understand is seperate to their aesthetics division. So it could also indicate they just want to focus on that even more?Comment
-
Yeah - I think JayM is right: http://www.reuters.com/article/2015/...1042OB20150725
Allergan sold the generic component of the company, but keeps the branded component. So they still have bim and seti - and now hopefully have more capital to invest in them.Comment
-
I think it's a good thing. Means they're comfortable with what they have now, and what's in their pipeline.Comment
-
Comment
Comment